ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.

Richard D Baird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.